Tenax Therapeutics CEO resigns; firm reviews strategic alternatives
Tenax Therapeutics Inc., a pharmaceutical firm in the critical care market, announced Friday that its chief executive John Kelley has resigned from the company. Morrisville-based Tenax also said its board has initiated a comprehensive review of strategic alternatives to current operations – a process that could result in the company being acquired. “This development does not change the focus or direction of the company, which remains dedicated to enhancing shareholder value through the development and commercialization of products for the critical care market,” said Tenax chair Ronald Blanck in a statement. The price of Tenax shares plummeted more than 75 percent in...
Read More